Single-Ascending Dose Study of MK-2060 in Healthy Chinese Male Adult Participants (MK-2060-009)
Clinical trial NCT06843993 · COMPLETED
Trial details
- NCT number
- NCT06843993
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2023-10-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.